AU3628293A - Hybrid DNA that codes for a subunit of a bacterial toxin with a hemolysin - Google Patents
Hybrid DNA that codes for a subunit of a bacterial toxin with a hemolysinInfo
- Publication number
- AU3628293A AU3628293A AU36282/93A AU3628293A AU3628293A AU 3628293 A AU3628293 A AU 3628293A AU 36282/93 A AU36282/93 A AU 36282/93A AU 3628293 A AU3628293 A AU 3628293A AU 3628293 A AU3628293 A AU 3628293A
- Authority
- AU
- Australia
- Prior art keywords
- hemolysin
- subunit
- codes
- hybrid dna
- bacterial toxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 231100000699 Bacterial toxin Toxicity 0.000 title abstract 2
- 108010006464 Hemolysin Proteins Proteins 0.000 title abstract 2
- 239000000688 bacterial toxin Substances 0.000 title abstract 2
- 239000003228 hemolysin Substances 0.000 title abstract 2
- 210000004900 c-terminal fragment Anatomy 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/25—Shigella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
A hybrid DNA is characterized in that a DNA structure that codes for a subunit of a bacterial toxin is fused with a H1yA (hemolysin)-coding DNA structure or its C-terminal fragment. Also disclosed are plasmides, host strains, oligohybridpeptides and vaccines obtained by use of said hybrid DNA.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4204737 | 1992-02-17 | ||
DE4204737 | 1992-02-17 | ||
DE4219696A DE4219696A1 (en) | 1992-02-17 | 1992-06-16 | HYBRID DNA, PLASMIDE, OLIGOHYBRIDEPEPTIDE AND VACCINE |
DE4219696 | 1992-06-16 | ||
PCT/EP1993/000348 WO1993016186A1 (en) | 1992-02-17 | 1993-02-12 | Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3628293A true AU3628293A (en) | 1993-09-03 |
AU672388B2 AU672388B2 (en) | 1996-10-03 |
Family
ID=25911935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU36282/93A Ceased AU672388B2 (en) | 1992-02-17 | 1993-02-12 | Hybrid DNA that codes for a subunit of a bacterial toxin with a hemolysin |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0627006B1 (en) |
JP (1) | JPH07505052A (en) |
AT (1) | ATE152483T1 (en) |
AU (1) | AU672388B2 (en) |
DE (2) | DE4219696A1 (en) |
DK (1) | DK0627006T3 (en) |
ES (1) | ES2104130T3 (en) |
WO (1) | WO1993016186A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2766193B1 (en) * | 1997-07-18 | 2001-09-14 | Inst Curie | CHEMICAL POLYPEPTIDE COMPRISING FRAGMENT B OF TOXIN SHIGA AND PEPTIDES OF THERAPEUTIC INTEREST |
US20020081307A1 (en) | 1998-05-15 | 2002-06-27 | Allan M. Green | Verotoxin b subunit for immunization |
US6264087B1 (en) | 1999-07-12 | 2001-07-24 | Powermed, Inc. | Expanding parallel jaw device for use with an electromechanical driver device |
EP1057895A1 (en) * | 1999-06-04 | 2000-12-06 | Lohmann Animal Health GmbH & Co. KG | Fusion protein comprising Shiga toxin 2e B subunit, (vaccine)compositions comprising it, and methods for their production |
-
1992
- 1992-06-16 DE DE4219696A patent/DE4219696A1/en not_active Withdrawn
-
1993
- 1993-02-12 ES ES93905242T patent/ES2104130T3/en not_active Expired - Lifetime
- 1993-02-12 WO PCT/EP1993/000348 patent/WO1993016186A1/en active IP Right Grant
- 1993-02-12 AU AU36282/93A patent/AU672388B2/en not_active Ceased
- 1993-02-12 EP EP93905242A patent/EP0627006B1/en not_active Expired - Lifetime
- 1993-02-12 DK DK93905242.9T patent/DK0627006T3/en active
- 1993-02-12 DE DE59306342T patent/DE59306342D1/en not_active Expired - Fee Related
- 1993-02-12 JP JP5513792A patent/JPH07505052A/en active Pending
- 1993-02-12 AT AT93905242T patent/ATE152483T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0627006B1 (en) | 1997-05-02 |
ATE152483T1 (en) | 1997-05-15 |
DE4219696A1 (en) | 1993-08-19 |
WO1993016186A1 (en) | 1993-08-19 |
DE59306342D1 (en) | 1997-06-05 |
JPH07505052A (en) | 1995-06-08 |
EP0627006A1 (en) | 1994-12-07 |
ES2104130T3 (en) | 1997-10-01 |
AU672388B2 (en) | 1996-10-03 |
DK0627006T3 (en) | 1997-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0692031A4 (en) | Heterologous antigens in live cell vaccine strains | |
MY121185A (en) | Recombinant antibodies for human therapy. | |
NZ331161A (en) | Synthetic HIV genes encoding envelope (env) proteins | |
WO1995006732A3 (en) | Bacterial exported proteins and acellular vaccines based thereon | |
AU584149B2 (en) | Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates | |
CA2138137A1 (en) | Diphtheria toxin vaccines | |
EP1203817A3 (en) | Compounds and methods for immunotherapy and diagnosis of tuberculosis | |
GR851120B (en) | ||
WO1998002546A3 (en) | Dna immunization against chlamydia infection | |
IL65565A (en) | Plasmids coding for b.thuringiensis crystal protein,their production and their use in creating genetically engineered bacterial strains | |
AUPM612494A0 (en) | Treatment or prevention of helicobacter infection | |
GB2331523B (en) | Vaccine production of the bacillus anthracis protective antigen | |
AU2751392A (en) | Vaccines for actinobacillus pleuropneumoniae | |
EP0077649A3 (en) | Cloning vectors for use in Streptomyces | |
HU9801384D0 (en) | Clostridium perfringeus vaccine | |
AU3628293A (en) | Hybrid DNA that codes for a subunit of a bacterial toxin with a hemolysin | |
WO1999011660A3 (en) | Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions | |
IE810618L (en) | Pasteurella vaccines | |
NZ332809A (en) | Immunogenic complex comprising a oligo- or polysaccharide epitope and a carrier protein with a portion of an OmpA-type outer membrane protein of a bacterial and vaccines of such complexes containing same | |
WO1999015669A3 (en) | Clostridium toxin, and method for preparing immunogenic compositions | |
EP0734451A4 (en) | ENTEROTOXINS OF -i(SHIGELLA FLEXNERI) 2a | |
AU4682685A (en) | Recombinant saccharomyces | |
EP0270077A3 (en) | Antibody to exotoxin of pseudomonas aeruginosa and gene therefor | |
AU3628193A (en) | Dysentery vaccine stimulating an immune response against shigatoxin, plasmids and host strains for it | |
GB9401795D0 (en) | Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |